DENOSUMAB (Xgeva®)
Clinical Indication
Prevention of skeletal related events in adults with bone metastases from solid tumours other than prostate
Comments
Red for patients with severe renal impairment (creatinine clearance less than 30ml/min)
Date of classification
May 2015
Red
Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.